181
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection

, , , , &
Pages 327-336 | Published online: 06 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Xiaoming Zhong, Jianqiong Yang, Hongyan Liu, Zhiwen Yang & Ping Luo. (2023) Potential lipid-based strategies of amphotericin B designed for oral administration in clinical application. Drug Delivery 30:1.
Read now
Aishwarya Jain & Sharvil Patil. (2022) Probing influence of nanocarrier structure on red blood cell membrane perturbations. Materials Technology 37:10, pages 1338-1345.
Read now
Pataranapa Nimtrakul, Pakawadee Sermsappasuk & Waree Tiyaboonchai. (2020) Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers. Drug Delivery 27:1, pages 1054-1062.
Read now
Sima Singh, Afzal Hussain, Faiyaz Shakeel, Mohamed Jawed Ahsan, Sultan Alshehri, Thomas J Webster & Uma Ranjan Lal. (2019) Recent insights on nanomedicine for augmented infection control. International Journal of Nanomedicine 14, pages 2301-2325.
Read now
Ronak Savla, Jeff Browne, Vincent Plassat, Kishor M. Wasan & Ellen K. Wasan. (2017) Review and analysis of FDA approved drugs using lipid-based formulations. Drug Development and Industrial Pharmacy 43:11, pages 1743-1758.
Read now
Divya Suares & Bala Prabhakar. (2017) Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery. Drug Development and Industrial Pharmacy 43:2, pages 213-224.
Read now
Mahasen A. Radwan, Bushra T. AlQuadeib, Lidija Šiller, Matthew C. Wright & Benjamin Horrocks. (2017) Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats . Drug Delivery 24:1, pages 40-50.
Read now
Min Liu, Meiwan Chen & Zhiwen Yang. (2017) Design of amphotericin B oral formulation for antifungal therapy. Drug Delivery 24:1, pages 1-9.
Read now
May S Freag, Yosra SR Elnaggar, Doaa A Abdelmonsif & Ossama Y Abdallah. (2016) Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies. International Journal of Nanomedicine 11, pages 4799-4818.
Read now

Articles from other publishers (12)

Ana Vitoria Pupo Silvestrini, Bryan Wender Debiasi, Fabíola Garcia Praça & Maria Vitoria Lopes Badra Bentley. (2022) Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies. International Journal of Pharmaceutics 628, pages 122299.
Crossref
Samuel Rodrigues dos Santos Junior, Andre Correa Amaral & Carlos Pelleschi Taborda. 2022. Nanotechnology for Infectious Diseases. Nanotechnology for Infectious Diseases 151 173 .
Michele Dully, Miriama Ceresnakova, David Murray, Tewfik Soulimane & Sarah P. Hudson. (2021) Lipid Cubic Systems for Sustained and Controlled Delivery of Antihistamine Drugs. Molecular Pharmaceutics 18:10, pages 3777-3794.
Crossref
Deize Evangelista Araújo, Amanda Alves de Oliveira, Mirlane dos Santos Cabral, Adelaide Fernandes Costa, Bárbara Carolina Silva, Lívia do Carmo Silva, Liliana Borges de Menezes, Célia Maria de Almeida Soares, Andre Correa Amaral & Maristela Pereira. (2020) Investigation of thiosemicarbazide free or within chitosan nanoparticles in a murine model of vulvovaginal candidiasis. Brazilian Journal of Microbiology 51:4, pages 1465-1473.
Crossref
Pataranapa Nimtrakul, Desmond B. Williams, Waree Tiyaboonchai & Clive A. Prestidge. (2020) Copolymeric Micelles Overcome the Oral Delivery Challenges of Amphotericin B. Pharmaceuticals 13:6, pages 121.
Crossref
Saugandha Das & Padma V. Devarajan. (2020) Enhancing Safety and Efficacy by Altering the Toxic Aggregated State of Amphotericin B in Lipidic Nanoformulations. Molecular Pharmaceutics 17:6, pages 2186-2195.
Crossref
Eman A. Hakeem, Galal M. El-Mahrouk, Ghada Abdelbary & Mahmoud H. Teaima. (2020) Freeze-Dried Clopidogrel Loaded Lyotropic Liquid Crystal: Box-Behnken Optimization, In-Vitro and In-Vivo Evaluation. Current Drug Delivery 17:3, pages 207-217.
Crossref
Eleni Kontogiannidou, Thomas Meikopoulos, Christina Virgiliou, Nikolaos Bouropoulos, Helen Gika, Ioannis S. Vizirianakis, Anette Müllertz & Dimitrios G. Fatouros. (2020) Towards the development of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) containing trimethyl chitosan for the oral delivery of amphotericin B: In vitro assessment and cytocompatibility studies. Journal of Drug Delivery Science and Technology 56, pages 101524.
Crossref
Faustino & Pinheiro. (2020) Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy. Pharmaceutics 12:1, pages 29.
Crossref
Jiali Zhai, Celesta Fong, Nhiem Tran & Calum J. Drummond. (2019) Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine. ACS Nano 13:6, pages 6178-6206.
Crossref
Fei Xia, Wufa Fan, Sifan Jiang, Yuhua Ma, Yi Lu, Jianping Qi, Ejaj Ahmad, Xiaochun Dong, Weili Zhao & Wei Wu. (2017) Size-Dependent Translocation of Nanoemulsions via Oral Delivery. ACS Applied Materials & Interfaces 9:26, pages 21660-21672.
Crossref
Paromita Kundu, Manasi Das, Kalpalata Tripathy & Sanjeeb K Sahoo. (2016) Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood–Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson’s Disease. ACS Chemical Neuroscience 7:12, pages 1658-1670.
Crossref